These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6086822)

  • 1. Genomic alterations associated with persistent infections by equine infectious anaemia virus, a retrovirus.
    Payne S; Parekh B; Montelaro RC; Issel CJ
    J Gen Virol; 1984 Aug; 65 ( Pt 8)():1395-9. PubMed ID: 6086822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.
    Salinovich O; Payne SL; Montelaro RC; Hussain KA; Issel CJ; Schnorr KL
    J Virol; 1986 Jan; 57(1):71-80. PubMed ID: 3001367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus.
    Montelaro RC; Parekh B; Orrego A; Issel CJ
    J Biol Chem; 1984 Aug; 259(16):10539-44. PubMed ID: 6206055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.
    Leroux C; Craigo JK; Issel CJ; Montelaro RC
    J Virol; 2001 May; 75(10):4570-83. PubMed ID: 11312327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
    Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
    Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
    Leroux C; Cadoré JL; Montelaro RC
    Vet Res; 2004; 35(4):485-512. PubMed ID: 15236678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique evolution of the s2 gene of equine infectious anemia virus in hosts correlated with particular infection statuses.
    Wang XF; Wang S; Liu Q; Lin YZ; Du C; Tang YD; Na L; Wang X; Zhou JH
    Viruses; 2014 Nov; 6(11):4265-79. PubMed ID: 25390683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.
    Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC
    Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.
    Hammond SA; Li F; McKeon BM; Cook SJ; Issel CJ; Montelaro RC
    J Virol; 2000 Jul; 74(13):5968-81. PubMed ID: 10846078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.
    Lichtenstein DL; Issel CJ; Montelaro RC
    J Virol; 1996 Jun; 70(6):3346-54. PubMed ID: 8648664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
    Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K
    Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course and extent of variation of equine infectious anemia virus during parallel persistent infections.
    Payne SL; Salinovich O; Nauman SM; Issel CJ; Montelaro RC
    J Virol; 1987 Apr; 61(4):1266-70. PubMed ID: 3029423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Kong X; Zhou J
    Arch Virol; 2011 Feb; 156(2):353-7. PubMed ID: 21136127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
    Howe L; Leroux C; Issel CJ; Montelaro RC
    J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic characterization by composite sequence analysis of a new pathogenic field strain of equine infectious anemia virus from the 2006 outbreak in Ireland.
    Quinlivan M; Cook F; Kenna R; Callinan JJ; Cullinane A
    J Gen Virol; 2013 Mar; 94(Pt 3):612-622. PubMed ID: 23175240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
    Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Genomic Variability in Equine Infectious Anemia Virus Obtained from Naturally Infected Horses in Pantanal, Brazil: An Endemic Region Case.
    Malossi CD; Fioratti EG; Cardoso JF; Magro AJ; Kroon EG; Aguiar DM; Borges AMCM; Nogueira MF; Ullmann LS; Araujo JP
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32059508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.
    Craigo JK; Leroux C; Howe L; Steckbeck JD; Cook SJ; Issel CJ; Montelaro RC
    J Gen Virol; 2002 Jun; 83(Pt 6):1353-1359. PubMed ID: 12029150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent elimination of EIAV ancestral species in a long-term inapparent carrier.
    Craigo JK; Sturgeon TJ; Cook SJ; Issel CJ; Leroux C; Montelaro RC
    Virology; 2006 Jan; 344(2):340-53. PubMed ID: 16226288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
    Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
    Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.